Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- February 2013
- DOI:
- 10.1371/journal.pone.0055790
- Bibcode:
- 2013PLoSO...855790Y